BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Update on 2026 Outlook and Company Progress

  July 1, 2026

   · 

  5 min read
• Press Releases

  Biovica Granted Japanese Patent for Immuno-Oncology

  July 1, 2026

   · 

  2 min read
• Press Releases

  Alvotech further strengthens liquidity by securing term loan facility of $75 million

  July 1, 2026

   · 

  5 min read
• Press Releases

  Faron Pharmaceuticals Ltd: Grant of Options - July 1, 2026

  July 1, 2026

   · 

  5 min read
• Press Releases

  Rezon Bio Appoints Dr. Hubert Scholze as Chief Business Officer to Accelerate Global Commercial Expansion

  July 1, 2026

   · 

  3 min read
• Press Releases

  Merck to Hold Second-Quarter 2026 Sales and Earnings Conference Call Aug. 4

  July 1, 2026

   · 

  3 min read
• 

  Duchenne muscular dystrophy

  Sarepta secures early 2027 FDA decision for Duchenne drugs, pushing past confirmatory fail

  Sarepta Therapeutics is seeking to convert the accelerated approval of its therapeutic exon-skippers for Duchenne muscular dystrophy to full despite the drugs’ failure to improve motor function in a confirmatory trial.

  July 1, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  The industrial chemistry behind creatine monohydrate: from synthesis to supplement

  July 1, 2026

   · 

  1 min read
• Press Releases

  Ocular Therapeutix™ to Participate in July 2026 Scientific and Investor Conferences

  July 1, 2026

   · 

  3 min read
• Press Releases

  Ocugen to Participate in Upcoming July 2026 Industry Conferences

  July 1, 2026

   · 

  4 min read